ACADIA Pharmaceuticals Inc.
ACAD | NASDAQ
$26.83
+$0.43 (+1.65%)
Sep 22, 2026, 10:51 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 307.96M | 268.06M | 283.99M | 278.63M | 264.57M | 244.32M | 259.6M | 250.4M | 241.96M | 205.83M | 231.04M | 211.7M | 165.24M | 118.46M | 136.49M | 130.71M | 134.56M | 115.47M | 130.76M | 131.61M | 115.22M | 106.55M |
Cost of Revenue | 28.32M | 24.79M | 26.23M | 21.65M | 20.73M | 20.39M | 21.8M | 18.86M | 18.23M | 22.95M | 17.89M | 14.62M | 7.46M | 1.67M | 2.41M | 2.14M | 2.67M | 2.95M | 2.56M | 6.68M | 5.21M | 4.69M |
Gross Profit | 279.64M | 243.27M | 257.76M | 256.99M | 243.83M | 223.93M | 237.8M | 231.54M | 223.73M | 182.88M | 213.15M | 197.08M | 157.78M | 116.8M | 134.08M | 128.58M | 131.9M | 112.52M | 128.2M | 124.93M | 110.02M | 101.86M |
Operating Income | 37.84M | -4.62M | 17.39M | 35.76M | 32.37M | 19.29M | 153.5M | 31.64M | 30.44M | 15.21M | 34.94M | -57.78M | 3.04M | -53.58M | -46.06M | -30.87M | -33.65M | -113.02M | -44.66M | -15.3M | -43.71M | -66.77M |
Interest Income | 7.99M | 8.06M | 8.33M | 8.25M | 7.24M | 7.9M | 7.01M | 6.59M | 6.36M | 5.51M | 4.76M | 4.13M | 4.55M | 3.8M | 3.63M | 2.3M | 580K | 105K | 129K | 129K | 133K | 200K |
Pretax Income | 46.47M | 3.98M | 26.32M | 44.6M | 40.21M | 27.78M | 161.09M | 38.81M | 37.18M | 21M | 39.7M | -52.14M | 6.34M | -44.94M | -40.89M | -26.42M | -33.57M | -112.57M | -42.91M | -14.79M | -43.4M | -66.43M |
Net Income | 31.5M | 3.64M | 273.57M | 71.78M | 26.67M | 18.99M | 143.74M | 32.77M | 33.39M | 16.56M | 45.8M | -65.18M | 1.11M | -43.02M | -41.73M | -27.18M | -34.01M | -113.06M | -43.09M | -14.46M | -43.87M | -66.45M |
Selling & General & Admin | 160.25M | 171.02M | 155.62M | 133.4M | 133.51M | 126.37M | 130.08M | 133.29M | 117.06M | 107.99M | 111.47M | 97.89M | 95.97M | 101.24M | 104.4M | 78.11M | 89.9M | 96.68M | 105.91M | 81.67M | 96.79M | 111.66M |
Research & Development | 81.56M | 76.87M | 84.76M | 87.83M | 77.95M | 78.27M | 100.73M | 66.61M | 76.23M | 59.68M | 66.74M | 156.96M | 58.77M | 69.14M | 75.74M | 81.34M | 75.65M | 128.86M | 66.94M | 58.57M | 56.94M | 56.97M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -146.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 241.81M | 247.89M | 240.37M | 221.23M | 211.46M | 204.64M | 84.3M | 199.9M | 193.3M | 167.67M | 178.21M | 254.85M | 154.74M | 170.38M | 180.14M | 159.44M | 165.55M | 225.53M | 172.85M | 140.23M | 153.72M | 168.63M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 270.12M | 272.68M | 266.6M | 242.88M | 232.19M | 225.03M | 106.1M | 218.76M | 211.53M | 190.62M | 196.1M | 269.48M | 162.2M | 172.05M | 182.55M | 161.58M | 168.21M | 228.48M | 175.42M | 146.91M | 158.93M | 173.33M |
Income Tax Expense | 14.97M | 344K | -247.25M | -27.18M | 13.55M | 8.79M | 17.34M | 6.04M | 3.79M | 4.45M | -6.09M | 13.03M | 5.23M | -1.92M | 835K | 768K | 443K | 485K | 189K | -332K | 473K | 21K |
Shares Outstanding (Basic) | 171.6M | 170.52M | 169.34M | 168.84M | 167.83M | 166.81M | 166.36M | 165.97M | 165.55M | 164.8M | 164.81M | 164.23M | 163.46M | 162.26M | 161.99M | 161.85M | 161.65M | 161.23M | 160.87M | 160.66M | 160.42M | 160.01M |
Shares Outstanding (Diluted) | 172.85M | 172.71M | 171.36M | 170.65M | 168.68M | 167.67M | 166.36M | 166.18M | 166.17M | 166.62M | 166.51M | 164.23M | 165.05M | 162.26M | 161.99M | 161.85M | 161.65M | 161.23M | 160.87M | 160.66M | 160.42M | 160.01M |
EPS (Basic) | 0.18 | 0.02 | 1.62 | 0.43 | 0.16 | 0.11 | 0.86 | 0.20 | 0.20 | 0.10 | 0.28 | -0.40 | 0.01 | -0.27 | -0.26 | -0.17 | -0.21 | -0.70 | -0.27 | -0.09 | -0.27 | -0.42 |
EPS (Diluted) | 0.18 | 0.02 | 1.60 | 0.42 | 0.16 | 0.11 | 0.86 | 0.20 | 0.20 | 0.10 | 0.28 | -0.40 | 0.01 | -0.27 | -0.26 | -0.17 | -0.21 | -0.70 | -0.27 | -0.09 | -0.27 | -0.42 |
EBITDA | 32.36M | 6.97M | 29.24M | 47.55M | 43.15M | 30.73M | 12.2M | 41.38M | 39.75M | 26.53M | 41.34M | -50.42M | 8.11M | -44.51M | -40.4M | -25.91M | -33.05M | -112.06M | -42.37M | -13.8M | -42.47M | -65.88M |
EBIT | 29.2M | 3.98M | 26.32M | 44.6M | 40.21M | 27.78M | 6.99M | 38.81M | 37.18M | 21M | 39.7M | -52.14M | 6.34M | -44.94M | -40.89M | -26.42M | -33.57M | -112.57M | -42.91M | -14.79M | -43.4M | -66.77M |
Depreciation & Amortization | 3.16M | 2.99M | 2.92M | 2.95M | 2.94M | 2.95M | 5.21M | 2.57M | 2.57M | 5.53M | 1.64M | 1.72M | 1.77M | 426K | 489K | 506K | 515K | 516K | 535K | 985K | 929K | 895K |
Add to Watchlist
Select watchlists to add or remove ACAD